Volume 15 Supplement 1
Proceedings of the International Cancer Imaging Society (ICIS) 15th Annual Teaching Course
Meeting abstracts
Publication charges for this supplement were funded through the International Cancer Imaging Society by support received from Siemens Healthcare GmbH.
International Cancer Imaging Society Meeting and 15th Annual Teaching Course (ICIS 2015). Go to conference site.
London, UK5-7 October 2015
Page 2 of 3
-
Citation: Cancer Imaging 2015 15(Suppl 1):P11
-
An imaging review of extramedullary myeloma
Citation: Cancer Imaging 2015 15(Suppl 1):P12 -
Patient experience of whole body diffusion weighted magnetic resonance imaging (WB-MRI) for staging myeloma
Citation: Cancer Imaging 2015 15(Suppl 1):P13 -
Radiogenomics of glioblastoma: a window into its imaging and molecular variability
Citation: Cancer Imaging 2015 15(Suppl 1):P14 -
Gadobenate dimeglumine (MultiHance) or gadoterat emeglumine (Dotarem) for brain tumour imaging? An intra-individual comparison
Citation: Cancer Imaging 2015 15(Suppl 1):P15 -
The value of head imaging after PET-CT staging in NSCLC
Citation: Cancer Imaging 2015 15(Suppl 1):P16 -
Relating neurological symptoms to cerebral metastases at the time of initial staging scan
Citation: Cancer Imaging 2015 15(Suppl 1):P17 -
Accuracy of MRI for prediction of response to neo-adjuvant chemotherapy in triple negative breast cancer
Citation: Cancer Imaging 2015 15(Suppl 1):P18 -
A pictorial series of interesting and unusual cases of breast malignancy encountered at triple assessment
Citation: Cancer Imaging 2015 15(Suppl 1):P19 -
The role of magnetic resonance imaging (MRI) in invasive lobular breast cancer based on mammographic density
Citation: Cancer Imaging 2015 15(Suppl 1):P20 -
Chemotherapy induced cardiomyopathy: an overview, imaging features, and future prospective
Citation: Cancer Imaging 2015 15(Suppl 1):P21 -
CT characteristic of early local recurrence after resection of the squamous cell carcinoma: comparison with CT characteristics of granulation tissue at stump site
Citation: Cancer Imaging 2015 15(Suppl 1):P22 -
4th year medical student elective in multidisciplinary thoracic oncology
Citation: Cancer Imaging 2015 15(Suppl 1):P23 -
Imaging spectrum of lung adenocarcinoma with histopathological correlation
Citation: Cancer Imaging 2015 15(Suppl 1):P24 -
Effects of body composition as measured by CT on clinical outcomes in patients with oesophageal cancer
Citation: Cancer Imaging 2015 15(Suppl 1):P25 -
Thoracic pseudotumours: a pictorial essay
Citation: Cancer Imaging 2015 15(Suppl 1):P26 -
Factors on patency periods of subcutaneous central venous port: long-term results of 1,408 patients
Citation: Cancer Imaging 2015 15(Suppl 1):P27 -
Are contouring time and multimodality imaging prognostic factors for radiation therapy of advanced head and neck cancer?
Citation: Cancer Imaging 2015 15(Suppl 1):P28 -
Reducing error: benign abnormalities mimicking malignancy when reporting scans of patients with known malignancy
Citation: Cancer Imaging 2015 15(Suppl 1):P29 -
Structured reporting of metastatic disease for improving communication in comprehensive cancer centers- a feasibility study
Citation: Cancer Imaging 2015 15(Suppl 1):P30 -
RECIST criteria: our experience in daily practice
Citation: Cancer Imaging 2015 15(Suppl 1):P31 -
Reporting oncoimaging in the appropriate oncology setting
Citation: Cancer Imaging 2015 15(Suppl 1):P32 -
Tractography of the prostatic neurovascular bundles: technique and interpretation
Citation: Cancer Imaging 2015 15(Suppl 1):P33 -
Detection of gynaecological cancer in pregnancy
Citation: Cancer Imaging 2015 15(Suppl 1):P34 -
Fertility preservation in gynaecologic malignancy: imaging role in treatment planning
Citation: Cancer Imaging 2015 15(Suppl 1):P35 -
MRI in intracavitary brachytherapy planning for cervical cancer malignancy, the pitfalls and complications
Citation: Cancer Imaging 2015 15(Suppl 1):P36 -
Pearls and pitfalls in diagnosing prostate cancer using multiparametric MRI (mpMRI)
Citation: Cancer Imaging 2015 15(Suppl 1):P37 -
Patient selection and treatment response assessment in radium-223 therapy
Citation: Cancer Imaging 2015 15(Suppl 1):P38 -
The value of 68Ga-PSMA enhanced PET-CT and MR-PET in patients with biochemical recurrent prostate cancer
Citation: Cancer Imaging 2015 15(Suppl 1):P39 -
Tumour characterisation, staging and operability assessment in ovarian carcinoma: whole body diffusion-weighted MRI versus CT
Citation: Cancer Imaging 2015 15(Suppl 1):P40 -
Efficacy of PI-RADS in prebiopsy prostate-MRI at a urological cancer centre: a comparison with histology
Citation: Cancer Imaging 2015 15(Suppl 1):P41 -
FDG-PET/CT pitfalls in gynecological and genitourinary oncological imaging
Citation: Cancer Imaging 2015 15(Suppl 1):P42 -
Role of high resolution MR in assessment of cervical uterine carcinoma: staging, treatment planning and correlation with histopathology findings
Citation: Cancer Imaging 2015 15(Suppl 1):P43 -
MRI rectal cancer in Australia and New Zealand: an audit from the PETACC-6 trial
Citation: Cancer Imaging 2015 15(Suppl 1):P44 -
Female pelvic malignancy: spectrum encountered in district hospital: an aid to a general radiologist
Citation: Cancer Imaging 2015 15(Suppl 1):P45 -
Do we need to wait? Does reducing time to prostate MRI postbiopsy interfere with staging?
Citation: Cancer Imaging 2015 15(Suppl 1):P46 -
Value of DWI volumetry for assessment of complete rectal cancer response after CRT
Citation: Cancer Imaging 2015 15(Suppl 1):P47 -
MR and PET/CT imaging in diagnosis of large pelvic masses
Citation: Cancer Imaging 2015 15(Suppl 1):P48 -
Imaging of pheochromocytoma and paraganglioma: moving beyond “lumpology” with SSTR, FDG and MIBG molecular imaging
Citation: Cancer Imaging 2015 15(Suppl 1):P49 -
Whole-body diffusion-weighted MRI for staging of women with cancer during pregnancy: a pilot study
Citation: Cancer Imaging 2015 15(Suppl 1):P50 -
Dual-energy CT in oncology: technical principles and clinical prospects
Citation: Cancer Imaging 2015 15(Suppl 1):P51 -
Value of DWI- ADC and FUSION T2-DWI in the management of oncological patients
Citation: Cancer Imaging 2015 15(Suppl 1):P52 -
The value of the FDG-GaTate and proliferation marker (ki-67) in the assessment of neuroendocrine tumours (NETs)
Citation: Cancer Imaging 2015 15(Suppl 1):P53 -
Multiparametric magnetic resonance tomography and MRI/TRUS-fusion-biopsy for index lesion detection: correlation with radical prostatectomy specimen
Citation: Cancer Imaging 2015 15(Suppl 1):S1 -
Pre-treatment ADC histogram-analysis at whole body diffusion-weighted MRI predicts disease free survival in ovarian cancer
Citation: Cancer Imaging 2015 15(Suppl 1):S5 -
Comparison of functional imaging in multiple myeloma patients: Indication for hybrid-imaging with PET/MRI?
Citation: Cancer Imaging 2015 15(Suppl 1):S6 -
Value of pretreatment MRI determined parameters for predicting outcome after radio-frequency ablation of hepatocellular carcinoma
Citation: Cancer Imaging 2015 15(Suppl 1):S7 -
Target versus non-target lesions in determining disease progression: analysis of 545 patients
Citation: Cancer Imaging 2015 15(Suppl 1):S8 -
Comparison of standard staging protocol and WB-MRI for initial staging of rectal cancer
Citation: Cancer Imaging 2015 15(Suppl 1):S9 -
Quantification of tumour heterogeneity and glucose metabolism on pre-chemoradiation PET/CT predicts survival in anal cancer
Citation: Cancer Imaging 2015 15(Suppl 1):S11
Currently, all abstracts in this supplement can be viewed using the Concatenated PDF 15S1.
Official journal of
-
Cancer Imaging is the official journal of the International Cancer Imaging Society (ICIS)
Follow
Annual Journal Metrics
-
2022 Citation Impact
4.9 - 2-year Impact Factor
4.7 - 5-year Impact Factor
1.636 - SNIP (Source Normalized Impact per Paper)
1.231 - SJR (SCImago Journal Rank)2023 Speed
13 days submission to first editorial decision for all manuscripts (Median)
123 days submission to accept (Median)2023 Usage
1,045,188 downloads
349 Altmetric mentions